Novel bulking agent for faecal incontinence

Novel bulking agent for faecal incontinence

BACKGROUND Various injectable bulking agents have been used for the treatment of faecal incontinence (FI). However, encouraging early results are not maintained over time. This study aimed to assess short- and medium-term results of a new bulking agent for the treatment of FI. METHODS The Gatekeeper(™) prosthesis comprises a thin solid polyacrylonitrile cylinder that becomes thicker, shorter ...

Injectable anal bulking agent for the management of faecal incontinence.

This study was conducted to determine the safety and efficacy of injectable bulking agents. A total of 13 procedures were performed on 11 patients with faecal incontinence during 2002 to 2007. Patients with internal anal sphincter defect and low incontinence score (Cleveland score < 10) revealed improvement. Patients with higher incontinence score and external sphincter defect secondary to obst...

Novel treatment of fecal incontinence with an injectable biocompatible tissue bulking agent.

MB Fecal incontinence is the inability to defer the urge to pass gas or stool until a socially acceptable time and place. It is estimated that fecal incontinence affects approximately 15 million individuals in the United States; however, this figure likely underestimates the true prevalence of this condition. It is estimated that approximately two thirds of the patients who suffer from fecal in...

Surgery for Faecal Incontinence

A new injectable bulking agent for treatment of stress urinary incontinence.

OBJECTIVES To assess the safety and effectiveness of Durasphere compared with bovine collagen in the treatment of stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). METHODS This multicenter, randomized, controlled, double-blind trial was composed of 355 women diagnosed with SUI due to ISD and used a standardized pad test and the Stamey continence grade as the prima...